Composition and biological activity of different extracts from Schisandra sphenanthera and Schisandra chinensis

Planta Medica

Volumn 73, Issue 10, 2007, Pages 1116-1126

  Huyke, Constance ^a   Engel, Kathrin ^a   Simon Haarhaus, Birgit ^a   Quirin, Karl Werner ^b   Schempp, Christoph M ^a,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Flavex Naturextrakte ^*  (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cyclooxygenase 2; Lignans; Schisandra chinensis; Schisandra sphenanthera; Schisandraceae; Schizandrins; Skin cancer; Ultraviolet B

Indexed keywords

ALCOHOL; CARBON DIOXIDE; CYCLOOXYGENASE 2; DEANGELOYLGOMISIN B; DEOXYSCHIZANDRIN; GAMMA SCHIZANDRIN; GOMISIN A; GOMISIN O; HEXANE; ISOGOMISIN O; LIGNAN DERIVATIVE; PLANT EXTRACT; PROSTAGLANDIN; SCHISANDRA CHINENSIS EXTRACT; SCHISANDRA SPHENANTHERA EXTRACT; SCHIZANDRIN; UNCLASSIFIED DRUG; VOLATILE AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CELL ASSAY; DOSE RESPONSE; ENZYME INHIBITION; EPIDERMIS CELL; HUMAN; HUMAN CELL; SPECTROSCOPY; ULTRAVIOLET B RADIATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUIT; HUMANS; KERATINOCYTES; PHYTOTHERAPY; PLANT EXTRACTS; SCHISANDRA;

SCHISANDRA; SCHISANDRA CHINENSIS; SCHISANDRA SPHENANTHERA; SCHISANDRACEAE;

EID: 34548606794     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981559     Document Type: Article

References (30)

1. Stöger EA. Arzneibuch der Chinesischen Medizin, 6. Ergänzungslieferung 9/1997. Stuttgart: Deutscher Apotheker Verlag; 1998.
2. Opletal L, Sovova H, Bartlova M. Dibenzo[a,c]cyclooctadiene lignans of the genus Schisandra: importance, isolation and determination. J Chromatogr B 2004; 812: 357-71.
3. Liu GT. Pharmacological actions and clinical use of Fructus Schizandrae. Chin Med J (Engl) 1989; 102: 740-9.
4. Ip SP, Poon MK, Wu SS, Che CT, Ng KH, Kong YC et al. Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity. Planta Med 1995; 61: 398-401.
5. Pan SY, Han YF, Carlier PR, Pang YP, Mak DH, Lam BY et al. Schisandrin B protects against tacrine- and bis(7)-tacrine-induced hepatotoxicity and enhances cognitive function in mice. Planta Med 2002; 68: 217-20.
6. Chiu PY, Mak DH, Poon MK, Ko KM. In vivo antioxidant action of a lignan-enriched extract of Schisandra fruit and an anthraquinone- containing extract of Polygonum root in comparison with schisandrin B and emodin. Planta Med 2002; 68: 951-6.
7. Wu MD, Huang RL, Kuo LM, Hung CC, Ong CW, Kuo YH. The anti-HBsAg (human type B hepatitis, surface antigen) and anti-HBeAg (human type B hepatitis, e antigen) C18 dibenzocyclooctadiene lignans from Kadsura matsudai and Schizandra arisanensis. Chem Pharm Bull 2003; 51: 1233-6.
8. Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S et al. Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill.) and Gan Cao (Glycyrrhiza uralensis Fisch.) activate PXR and increase warfarin clearance in rats. J Pharmacol Exp Ther 2005; 316: 1369-77.
9. Chen DF, Zhang SX, Wang HK, Zhang SY, Sun QZ, Cosentino LM et al. Novel anti-HIV lancilactone C and related triterpenes from Kadsura lancilimba. J Nat Prod 1999; 62: 94-7.
10. Li RT, Han QB, Zheng YT, Wang RR, Yang LM, Lu Y et al. Structure and anti-HIV activity of micrandilactones B and C, new nortriterpenoids possessing a unique skeleton from Schisandra micrantha. Chem Commun (Camb) 2005; 23: 2936-8.
11. Xiao WL, Tian RR, Pu JX, Li X, Wu L, Lu Y et al. Triterpenoids from Schisandra lancifolia with anti-HIV-1 activity. J Nat Prod 2006; 69: 277-9.
12. Lee IS, Lee HK, Dat NT, Lee MS, Kim JW, Na DS et al. Lignans with inhibitory activity against NFAT transcription from Schisandra chinensis. Planta Med 2003; 69: 63-4.
13. Chen YG, Wu ZC, Lv YP, Gui SH, Wen J, Liao XR et al. Triterpenoids from Schisandra henryi with cytotoxic effect on leukemia and Hela cells in vitro. Arch Pharm Res 2003; 26: 912-6.
14. Chen YG, Wu ZC, Gui SH, Lv YP, Liao XR, Halaweish F. Lignans from Schisandra henryi with DNA cleaving activity and cytotoxic effect on leukemia and Hela cells in vitro. Fitoterapia 2005; 76: 370-3.
15. Yasukawa K, Ikeya Y, Mitsuhashi H, Iwasaki M, Aburada M, Nakagawa S et al. Gomisin A inhibits tumor promotion by 12-O-tetradecanoyl-phorbol 13-acetate in two-stage carcinogenesis in mouse skin. Oncology 1992; 49: 68-71.
16. Ohkura Y, Mizoguchi Y, Morisawa S, Takeda S, Aburada M, Hosoya E. Effect of gomisin A (TJN-101) on the arachidonic acid cascade in macrophages. Jpn J Pharmacol 1990; 52: 331-6.
17. 2 fluid extract and separation of components from fruits of Schisandra sphenanthera. Zhongguo Zhong Yao Za Zhi 2001; 26: 755-7.
18. Popov I, Lewin G. Photochemiluminescent detection of antiradical activity. VII. Comparison with a modified method of thermo-initiated free radical generation with chemiluminescent detection. Luminescence. 2005; 20: 21-5.
19. Schempp CM, Kirkin V, Simon-Haarhaus B, Kersten A, Kiss J, Termeer CC et al. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 2002; 21: 1242-50.
20. Schempp CM, Kiss J, Kirkin V, Averbeck M, Simon-Haarhaus B, Kremer B et al. Hyperforin acts as an angiogenesis inhibitor in vitro and in vivo. Planta Med 2005; 71: 999-1004.
21. Jocher A, Kessler S, Hornstein S, Schulte Mönting J, Schempp CM. The UV-erythema test as a model to investigate the anti-inflammatory potency of topical preparations. Re-evaluation and optimization of the method. Skin Pharmacol Physiol 2005; 18: 234-40.
22. Laszczyk M, Jager S, Simon-Haarhaus B, Scheffler A, Schempp CM. Physical, chemical and pharmacological characterization of a new oleogel-forming triterpene extract from the outer bark of birch (betulae cortex). Planta Med 2006; 72: 1389-95.
23. 2. J Biol Chem 1999; 274: 11660-6.
24. Danz H, Stoyanova S, Wippich P, Brattstrom A, Hamburger M. Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria. Planta Med 2001; 67: 411-6.
25. Danz H, Stoyanova S, Thomet OA, Simon HU, Dannhardt G, Ulbrich H et al. Inhibitory activity of tryptanthrin on prostaglandin and leukotrienee synthesis. Planta Med 2002; 68: 875-80.
26. Isoherranen K, Punnonen K, Jansen C, Uotila P. Ultraviolet irradiation induces cyclooxygenase-2 expression in keratinocytes. Br J Dermatol 1999; 140: 1017-22.
27. Muller-Decker K. Cyclooxygenases in the skin. J Dtsch Dermatol Ges 2004; 2: 668-75.
28. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996; 97: 672-9.
29. Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998; 19: 723-9.
30. Hamburger M, Baumann D, Adler S. Supercritical carbon dioxide extraction of selected medicinal plants - effects of high pressure and added ethanol on yield of extracted substances. Phytochem Anal 2004; 15: 46-54.